- Home
- TECH vs REXR Comparison
TECH vs REXR Comparison
Compare TECH & REXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- REXR
- Stock Information
- Founded
- TECH 1976
- REXR 2013
- Country
- TECH United States
- REXR United States
- Employees
- TECH N/A
- REXR N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- REXR Real Estate Investment Trusts
- Sector
- TECH Health Care
- REXR Real Estate
- Exchange
- TECH Nasdaq
- REXR Nasdaq
- Market Cap
- TECH 8.3B
- REXR 8.6B
- IPO Year
- TECH 1989
- REXR 2013
- Fundamental
- Price
- TECH $51.52
- REXR $42.27
- Analyst Decision
- TECH Buy
- REXR Hold
- Analyst Count
- TECH 12
- REXR 9
- Target Price
- TECH $70.91
- REXR $40.78
- AVG Volume (30 Days)
- TECH 2.1M
- REXR 2.7M
- Earning Date
- TECH 10-29-2025
- REXR 10-15-2025
- Dividend Yield
- TECH 0.62%
- REXR 4.07%
- EPS Growth
- TECH N/A
- REXR 11.21
- EPS
- TECH 0.46
- REXR 1.35
- Revenue
- TECH $1,219,635,000.00
- REXR $986,532,000.00
- Revenue This Year
- TECH $4.13
- REXR $9.35
- Revenue Next Year
- TECH $7.56
- REXR $6.25
- P/E Ratio
- TECH $112.02
- REXR $31.39
- Revenue Growth
- TECH 5.23
- REXR 13.72
- 52 Week Low
- TECH $46.01
- REXR $29.68
- 52 Week High
- TECH $80.95
- REXR $52.37
- Technical
- Relative Strength Index (RSI)
- TECH 43.21
- REXR 59.89
- Support Level
- TECH $50.96
- REXR $42.50
- Resistance Level
- TECH $54.62
- REXR $43.79
- Average True Range (ATR)
- TECH 1.90
- REXR 0.83
- MACD
- TECH -0.34
- REXR -0.06
- Stochastic Oscillator
- TECH 13.01
- REXR 59.25
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.